Back to Journals » Therapeutics and Clinical Risk Management » Volume 2 » Issue 3

SJR OA
CiteScore
Impact Factor

Therapeutics and Clinical Risk Management

ISSN: 1178-203X


       

Archive: Volume 2, 2006


Effectiveness of lifestyle measures in the treatment of gastroesophageal reflux disease – a case series

Madeleine Nowak, Petra Büttner, Simone Harrison, Kym Daniell, Beverly Raasch, Rick Speare

Therapeutics and Clinical Risk Management 2006, 2:329-334

Published Date: 15 September 2006

An assessment of the cost-utility of therapy for psoriasis

Stefan C Weiss, Wingfield Rehmus, Alexa B Kimball

Therapeutics and Clinical Risk Management 2006, 2:325-328

Published Date: 15 September 2006

Cost-effectiveness of hypothetical new cancer drugs in patients with advanced small-cell lung cancer: results of a markov chain model

Carin A Uyl-de Groot, Joseph McDonnell, Guul ten Velde, David Radice, Harry J M Groen

Therapeutics and Clinical Risk Management 2006, 2:317-323

Published Date: 15 September 2006

Impact of introducing anticoagulation-related prescribing guidelines in a hospital setting using academic detailing

Gregory William Roberts, Robert Adams

Therapeutics and Clinical Risk Management 2006, 2:309-316

Published Date: 15 September 2006

Frovatriptan: a review of pharmacology, pharmacokinetics and clinical potential in the treatment of menstrual migraine

Ebrahim A Balbisi

Therapeutics and Clinical Risk Management 2006, 2:303-308

Published Date: 15 September 2006

Oral paricalcitol for the treatment of secondary hyperparathyroidism in chronic kidney disease

Steven Cheng, Daniel Coyne

Therapeutics and Clinical Risk Management 2006, 2:297-301

Published Date: 15 September 2006

Management of age-related osteoporosis and prevention of associated fractures

Eric J MacLaughlin, Rebecca B Sleeper, Danny McNatty, Cynthia L Raehl

Therapeutics and Clinical Risk Management 2006, 2:281-295

Published Date: 15 September 2006

Bortezomib (Velcade™) in the treatment of multiple myeloma

Antonia Field-Smith, Gareth J Morgan, Faith E Davies

Therapeutics and Clinical Risk Management 2006, 2:271-279

Published Date: 15 September 2006

Progress in the development of a cervical cancer vaccine

Ursula Winters, Richard Roden, Henry Kitchener, Peter Stern

Therapeutics and Clinical Risk Management 2006, 2:259-269

Published Date: 15 September 2006

Cancer treatment-induced mucositis pain: strategies for assessment and management

Debra J Harris

Therapeutics and Clinical Risk Management 2006, 2:251-258

Published Date: 15 September 2006

Alendronate sodium in the management of osteoporosis

P J J Prinsloo, DJ Hosking

Therapeutics and Clinical Risk Management 2006, 2:235-249

Published Date: 15 September 2006

Oxycodone controlled release in cancer pain management

Giuseppe Biancofiore

Therapeutics and Clinical Risk Management 2006, 2:229-234

Published Date: 15 September 2006

Editorial ||FREE PAPER||

Garry Walsh

Therapeutics and Clinical Risk Management 2006, 2:227-228

Published Date: 15 September 2006